Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
E-Books/E-Docs

Title Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer [electronic resource].

Imprint [Rockville, Md. : U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999]

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  HE 20.6524:4/SUM.    ---  Available
Series Evidence report/technology assessment. Summary ; no. 4
AHCPR publication ; no. 99-E011
AHCPR pub. ; no. 99-E 011.
System Details Mode of access via the AHCPR web site.
Note Title from title screen (viewed on Apr. 29, 2004).
"January 1999."
"The full evidence report from which this summary was taken was prepared by the Evaluation Technology Center, an AHCPR Evidence-based Practice Center of the Blue Cross and Blue Shield Association, Chicago, Illinois, under contract no. 290-97-0015."
Subject Prostate -- Cancer -- Hormone therapy.
Antiandrogens -- Therapeutic use.
Androgen Antagonists -- therapeutic use.
Cost-Benefit Analysis.
Gonadorelin -- antagonists & inhibitors.
Outcome Assessment (Health Care)
Prostatic Neoplasms -- drug therapy.
Randomized Controlled Trials.
Added Author United States. Agency for Health Care Policy and Research.
Blue Cross and Blue Shield Association. Evaluation Technology Center.
Other Form: Relative effectiveness and cost-effectiveness of methods of andogen suppression in the treatment of advanced prostatic cancer [6] p. (OCoLC)43871810
Gpo Item No. 0491-B-31 (online)
Sudoc No. HE 20.6524:4/SUM.

 
    
Available items only